Although a previous study indicated potential for UCC118TM strain in an IL-10-deficient mouse model of chronic colitis [15,20], it has remained unclear until now whether Lactobacillus salivarius UCC118TM could be a good candidate for the treatment of IBD. This evidence concerns the gene IL10 and inflammatory bowel disease.